Form 4: DexCom Director Karen M. Dahut Reports Acquisition of 2,613 Shares of Common Stock

Karen M. Dahut, a director of DexCom Inc., reported acquiring 2,613 shares of common stock on May 22, 2024, through a restricted stock unit (RSU) award.

Summary

• On May 22, 2024, Karen M. Dahut, a director of DexCom Inc., acquired 2,613 shares of DexCom's common stock.
• The acquisition was made through a restricted stock unit (RSU) award.
• The RSU award vests on the earlier of the one-year anniversary of the grant date or DexCom's 2025 Annual Meeting of Stockholders.
• Following the transaction, Ms. Dahut directly owns 2,613 shares and indirectly owns 15,166 shares through a trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it is a standard disclosure of stock acquisition by a company director. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Positives

• The acquisition of shares by a director may signal confidence in the company's future prospects.

Future Outlook

The RSU award will vest on the earlier of the one-year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders.

Industry Context

This filing is a routine disclosure of stock ownership changes by a company insider, which is common in publicly traded companies like DexCom.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates